Abstract
Granzyme B is a caspase-like serine protease that is released by cytotoxic lymphocytes to kill virus-infected and tumor cells. Major recent advances in our understanding of granzyme B biochemistry, biology and function include an appreciation of its uptake into and trafficking within target cells, a thorough dissection of how cell death is triggered, and the identification of the serpin protease inhibitor PI-9, which regulates its function in lymphocytes and in other cells. The roles that granzyme B plays in human pathologies, such as transplant rejection, viral immunity and particularly tumor immune surveillance, remain a topic for vigorous debate and conjecture. The recent discovery of a triply mutated human granzyme B allele, whose product is predicted to possess a reduced capacity to induce cell death, opens the way for major progress in these areas in coming years.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Apoptosis / immunology*
-
Apoptosis / physiology
-
BH3 Interacting Domain Death Agonist Protein
-
Carrier Proteins / physiology
-
Graft Rejection / enzymology
-
Granzymes
-
Humans
-
Membrane Glycoproteins / metabolism
-
Mitochondria / metabolism
-
Neoplasms / enzymology
-
Neoplasms / immunology*
-
Perforin
-
Pore Forming Cytotoxic Proteins
-
Receptor, IGF Type 2 / metabolism
-
Serine Endopeptidases / physiology*
-
Serpins / metabolism
-
Serpins / physiology
-
Signal Transduction
-
Substrate Specificity
-
T-Lymphocytes, Cytotoxic / enzymology
-
Virus Diseases / enzymology
-
Virus Diseases / immunology*
Substances
-
BH3 Interacting Domain Death Agonist Protein
-
BID protein, human
-
Carrier Proteins
-
Membrane Glycoproteins
-
Pore Forming Cytotoxic Proteins
-
Receptor, IGF Type 2
-
SERPINB9 protein, human
-
Serpins
-
Perforin
-
GZMB protein, human
-
Granzymes
-
Serine Endopeptidases